SOFTMEDX (00648) Issues Approximately 16.3 Million Scheme Shares at 96% Discount

Stock News
03/10

SOFTMEDX (00648) announced that, due to a continued deterioration of its financial condition since trading was suspended, the company resolved in 2023 to proceed with a debt restructuring via a scheme. In December 2023, the scheme was registered with the Companies Registry and became effective. To fulfill the scheme's requirements, the company must issue 16,301,841 scheme shares to creditors at an issue price of HK$0.01 per share within six months from the resumption of trading. The issue price represents a 96% discount to the closing price of HK$0.28 per share as quoted on the Stock Exchange on the date of this announcement.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10